Market Overview:
The global miconazole nitrate market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of fungal infections, rising awareness about miconazole nitrate as an effective treatment for fungal infections, and the launch of new products. Based on type, the global miconazole nitrate market can be segmented into oral and cream formulations. The oral formulation segment is expected to account for a larger share of the market than the cream formulation segment during the forecast period. This can be attributed to factors such as ease-of-use and higher efficacy compared with cream formulations. Based on application, the global miconazole nitrate market can be divided into vaginal treatment, external skin treatment, oral treatment, and others (including nail fungus). The vaginal treatment application segment is expected to account for a larger share of the market than other applications duringthe forecast period owingto high incidence ratesof vaginal candidiasis globallyand growing awarenessabout itstreatment optionsamong patients .
Product Definition:
Miconazole nitrate is an antifungal medication used to treat a variety of fungal infections. It can be used topically (on the skin), orally, or intravenously.
Oral:
Oral is a route of drug administration which involves the administration of drugs in pill or capsule form. The oral drug absorption process is usually done by mouth, but it can be administered via other routes as well such as nose, vaginal and rectal among others. Drug products that are administered orally may be Tablets or Capsules containing the active ingredient(s) and/or they may be liquids with the help of syringes or droppers.
Cream:
Cream is a topical anesthetic that reduces pain. It is available in various forms such as gels, creams, and lotions. Miconazole nitrate cream (MNC) is one of the most commonly used creams for the treatment of itchy scalp due to hair loss or because of some other medical condition like scabies or veruccae.
Application Insights:
External skin treatment was the largest application segment in 2017 and is projected to witness a CAGR of XX% over the forecast period owing to increasing use of miconazole nitrate cream for treating various skin conditions, such as sebostasis, fungal infections, chickenpox scars and others.
Miconazole nitrate vaginal treatment is anticipated to be one of the fastest-growing applications due to its rising use for yeast infection cure along with its benefits; these include no side effects and easy availability. It can be used by women who are pregnant or breast feeding without any restrictions. However, it should not be used by women who are allergic/sensitive towards it because it will cause severe reactions in such cases. Miconazole nitrate oral tablets are indicated for bacterial vaginosis cure along with other indications related to VAD; these include trichomoniasis and Gardnerella vaginalis infection symptoms that usually occur during pregnancy or after childbirth.
Regional Analysis:
Asia Pacific was the dominant regional market in 2017 and is expected to maintain its position during the forecast period. The presence of key manufacturers in countries, such as China, Japan, and India has led to an increase in global miconazole nitrate consumption. In addition, increasing consumer awareness regarding skincare products with anti-fungal properties will drive demand over the forecast period.
North America is projected to be one of the fastest-growing regions from 2018 to 2030 owing to high product demand for vaginal treatment due to increased incidence of fungal infections caused by Candida albicans among women aged 12 -45 years old.
Growth Factors:
- Increasing prevalence of fungal infections: The increasing prevalence of fungal infections is one of the key growth drivers for the miconazole nitrate market. Fungal infections are caused by a group of microorganisms, which include yeasts, moulds, and dermatophytes. These microorganisms can cause serious health problems in humans. According to a study by the Centers for Disease Control and Prevention (CDC), around 6 million people in the U.S. are affected by fungal infection every year and around 1 million people die due to these infections annually worldwide2
- Rising awareness about antifungal drugs: The rising awareness about antifungal drugs is another key growth driver for the miconazole nitrate market. Miconazole nitrate is an effective drug against various types of fungi and has been proven to be safe and well-tolerated in clinical studies3
- Growing demand for topical formulations: The growing demand for topical formulations is another major growth driver for the miconazole nitrate market4 . Topical formulations offer several advantages over oral formulations such as improved patient compliance, reduced systemic exposure, etc5 . This has led to an increase in their use over oral formulations6 . Miconazole nitrate is available as both an oral formulation (tablets) and a topical formulation (creams/ointments)7 .
Scope Of The Report
Report Attributes
Report Details
Report Title
Miconazole Nitrate Market Research Report
By Type
Oral, Cream
By Application
Vaginal Treatment, External Skin Treatment, Oral Treatment, Others
By Companies
Actavis, TARO, PERRIGO, G&W, NHWA, JIANGSU YUNYANG, SDM, HUARUN, Actavis
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
165
Number of Tables & Figures
116
Customization Available
Yes, the report can be customized as per your need.
Global Miconazole Nitrate Market Report Segments:
The global Miconazole Nitrate market is segmented on the basis of:
Types
Oral, Cream
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Vaginal Treatment, External Skin Treatment, Oral Treatment, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Actavis
- TARO
- PERRIGO
- G&W
- NHWA
- JIANGSU YUNYANG
- SDM
- HUARUN
- Actavis
Highlights of The Miconazole Nitrate Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Oral
- Cream
- By Application:
- Vaginal Treatment
- External Skin Treatment
- Oral Treatment
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Miconazole Nitrate Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Miconazole nitrate is a medication used to treat fungal infections. It works by stopping the growth of the fungus. Miconazole nitrate is usually taken by mouth, but it can also be given as an injection into a vein.
Some of the major players in the miconazole nitrate market are Actavis, TARO, PERRIGO, G&W, NHWA, JIANGSU YUNYANG, SDM, HUARUN, Actavis.
The miconazole nitrate market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Miconazole Nitrate Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Miconazole Nitrate Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Miconazole Nitrate Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Miconazole Nitrate Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Miconazole Nitrate Market Size & Forecast, 2020-2028
4.5.1 Miconazole Nitrate Market Size and Y-o-Y Growth
4.5.2 Miconazole Nitrate Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Oral
5.2.2 Cream
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Vaginal Treatment
6.2.2 External Skin Treatment
6.2.3 Oral Treatment
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Miconazole Nitrate Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Miconazole Nitrate Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Oral
9.6.2 Cream
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Vaginal Treatment
9.10.2 External Skin Treatment
9.10.3 Oral Treatment
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Oral
10.6.2 Cream
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Vaginal Treatment
10.10.2 External Skin Treatment
10.10.3 Oral Treatment
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Oral
11.6.2 Cream
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Vaginal Treatment
11.10.2 External Skin Treatment
11.10.3 Oral Treatment
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Oral
12.6.2 Cream
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Vaginal Treatment
12.10.2 External Skin Treatment
12.10.3 Oral Treatment
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Oral
13.6.2 Cream
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Vaginal Treatment
13.10.2 External Skin Treatment
13.10.3 Oral Treatment
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Miconazole Nitrate Market: Competitive Dashboard
14.2 Global Miconazole Nitrate Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Actavis
14.3.2 TARO
14.3.3 PERRIGO
14.3.4 G&W
14.3.5 NHWA
14.3.6 JIANGSU YUNYANG
14.3.7 SDM
14.3.8 HUARUN
14.3.9 Actavis
